Private Equity stories
Investors overseeing USD $350 billion in assets will join more than 300 startups in Singapore as AI shifts towards industrial uses.
Missed calls at small firms are becoming a bigger revenue risk as Newo expands its AI receptionist tools beyond the US and into Europe.
Enterprise buyers are turning to Azul to cut Java costs and risks, with finance, healthcare and telecoms driving a 43% bookings rise.
Consumer goods groups could speed products into stores as the consultancy tie-up links operating changes to live sales data and AI.
AI-driven automation is set to force most SaaS groups away from seat-based fees within two years, a survey of 300 CEOs shows.
The AI fund administration software maker now serves more than 80 managers after its AUD $9.3 million raise and rapid growth.
Retail investors can now buy into pre-IPO exposure to SpaceX through a tokenised product as exchanges seek new fee streams.
The deal caps rapid expansion at the Northern Ireland manufacturer, which lifted revenue 84% and added 300,000 square feet under Foresight.
The London-based firm gains fresh firepower to expand in North America as scrutiny grows over losses from unhedged currency exposure.
The deal gives private equity clients wider Salesforce support across sales, pricing and revenue systems, plus delivery teams in three regions.
Private equity-backed businesses are adopting paid AI tools faster than the wider market, yet still lag venture-funded peers on full rollout.
The cloud and managed services provider is sharpening its push into the US and wider markets as it adds senior commercial firepower.
Investor appetite for AI remains intense as OpenAI's new cash haul lifts its valuation to USD $852 billion and deepens its compute push.
The handover aims to steady Syspro’s expansion as manufacturers and distributors demand more automation, data tools and industry-specific software.
Technology dealmaking fell sharply as investors redirected capital towards artificial intelligence, with UK bolt-on volumes dropping to 44 in 2025.
Enterprise users are turning to Azul to cut Java cloud costs and compliance risks as finance, healthcare and telecoms demand jumped sharply.
The move gives UK life sciences firms a new source of scale-up capital as a funding gap has left many promising businesses short of backing.
The merger drive has prompted a New York office opening and new leadership aimed at sharpening Alchelyst's sales, operations and investor services.
Backers including the British Business Bank have helped lift the London firm’s assets under management to USD $200 million and support 30 startups.
The investment firm is shifting towards regular portfolio realisations after two major sales, as Antonia Jenkinson takes over the finance brief.